CDC2L5 HEK293 Cell Transient Overexpression Lysate(Non-Denatured)
CDK13
IP, WB
Whole Cell Lysate
Overexpression Lysate
HEK 293T Cells
Reactivité: Humain
-
- Antigène Tous les produits CDK13
- CDK13 (Cyclin-Dependent Kinase 13 (CDK13))
- Espèce de la protéine
- Humain
- Espèce du lysat
- Human Cells
- Application
- Immunoprecipitation (IP), Western Blotting (WB)
- Fonction
- Transient Overexpression Lysate
- Specificité
- Non-denatured
- Attributs du produit
-
CDC2L5 HEK293 Cell Transient Overexpression Lysate (Non-Denatured)
Used Plasmid: pCMV-CDC2L5 full length - Lysed Cells
- HEK 293T Cells
- Lysate Type
- Overexpression Lysate
- Lysate Fraction
- Whole Cell Lysate
-
- Indications d'application
- Use it directly for immuno-precipitation, or heat lysate with SDS gel loading buffer to 95 °C for 5 minutes followed by rapid cooling for western blot application. If dissociating conditions are required, add reducing agent prior to heating.
- Commentaires
-
Product Quality tested by: Transient overexpression cell lysate was tested with Anti-CDC2L5 antibody by Western Blots.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 2 mg/mL
- Buffer
- Modified RIPA Lysis Buffer:50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 % Triton X-100, 0.1 % SDS, 1 % Sodium deoxycholate, 1 mM PMSF.
- Conseil sur la manipulation
- Aliquot to avoid repeated freezing and thawing.
- Stock
- -80 °C
- Stockage commentaire
- Store at -80 °C. Aliquot to avoid repeated freezing and thawing.
-
- Antigène
- CDK13 (Cyclin-Dependent Kinase 13 (CDK13))
- Autre désignation
- CDC2L5 (CDK13 Produits)
- Synonymes
- CDC2L5 Lysate, cdc2l5 Lysate, wu:fe16d10 Lysate, wu:fi49c05 Lysate, CDC2L Lysate, CHED Lysate, hCDK13 Lysate, 2310015O17Rik Lysate, Cdc2l5 Lysate, cyclin dependent kinase 13 Lysate, cyclin-dependent kinase 13 Lysate, CDK13 Lysate, cdk13 Lysate, Cdk13 Lysate
- Sujet
-
Full Gene Name: cell division cycle 2-like 5 (cholinesterase-related cell division controller)
Synonyms: CDC2L,CHED,FLJ35215,KIAA1791 - ID gène
- 8621
-
Vous êtes ici:
